CODX Co-Diagnostics, Inc.

Nasdaq codiagnostics.com


$ 0.34 $ -0.01 (-1.94 %)    

Tuesday, 21-Oct-2025 17:13:42 EDT
QQQ $ 610.98 $ -0.16 (-0.03 %)
DIA $ 469.35 $ 2.20 (0.47 %)
SPY $ 671.46 $ -0.01 (0 %)
TLT $ 92.00 $ 0.45 (0.49 %)
GLD $ 379.37 $ -25.91 (-6.43 %)
$ 0.3391
$ 0.35
$ 0.34 x 1,000
$ 0.36 x 900
$ 0.33 - $ 0.36
$ 0.23 - $ 1.29
479,859
na
13.06M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-10-2018 06-30-2018 10-Q
30 05-14-2018 03-31-2018 10-Q
31 03-28-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-25-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 co-diagnostics-enters-equity-distribution-agreement-with-maxim-group-may-sell-common-stock-up-to-10m-from-time-to-time

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001692415/000149315225018591/form8-k.htm

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-3-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

 d-boral-capital-maintains-buy-on-co-diagnostics-lowers-price-target-to-3

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $1...

 co-diagnostics-announces-38m-registered-direct-offering-of-9619m-shares-at-a-price-of-040share

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, p...

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-10-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $10 price target.

 co-diagnostics-stock-plunges-28-in-pre-market-despite-strategic-saudi-partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partner...

 co-diagnostics-confirms-chikv-test-effectiveness-against-recent-strains-with-in-silico-analysis

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, p...

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-10-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $10 price target.

 co-diagnostics-q2-eps-023-beats-066-estimate-sales-162910k-beat-150000k-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.66...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION